Literature DB >> 26855156

Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants.

S Masouridi-Levrat1, F Simonetta1, Y Beauverd1, O Tsopra1, Y Tirefort1, C Stephan1, E Levrat2, M Ansari1, F Verholen3, E Roosnek1, J R Passweg4, Y Chalandon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26855156     DOI： 10.1038/bmt.2015.356

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

Authors:  Judith C Marsh; Vikas Gupta; Ziyi Lim; Aloysius Y Ho; Robin M Ireland; Janet Hayden; Victoria Potter; Mickey B Koh; M Serajul Islam; Nigel Russell; David I Marks; Ghulam J Mufti; Antonio Pagliuca
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

2.  Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus-leukemia reaction? A prospective phase II study.

Authors:  Yves Chalandon; Eddy Roosnek; Bernadette Mermillod; Laurent Waelchli; Claudine Helg; Bernard Chapuis
Journal:  Biol Blood Marrow Transplant       Date:  2006-01       Impact factor: 5.742

3.  Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.

Authors:  Andrea Bacigalupo; Gérard Socié; Hubert Schrezenmeier; Andre Tichelli; Anna Locasciulli; Monika Fuehrer; Antonio M Risitano; Carlo Dufour; Jakob R Passweg; Rosi Oneto; Mahmoud Aljurf; Catherine Flynn; Valerie Mialou; Rose Marie Hamladji; Judith C W Marsh
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

4.  Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.

Authors:  Richard E Champlin; Waleska S Perez; Jakob R Passweg; John P Klein; Bruce M Camitta; Eliane Gluckman; Christopher N Bredeson; Mary Eapen; Mary M Horowitz
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

5.  Implications of CD34+ cell dose on clinical and haematological outcome of allo-SCT for acquired aplastic anaemia.

Authors:  M S Islam; P Anoop; P Datta-Nemdharry; D Sage; E C Gordon-Smith; D Turner; S Wiltshire; L O'Regan; J C W Marsh
Journal:  Bone Marrow Transplant       Date:  2009-10-12       Impact factor: 5.483

6.  Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.

Authors:  Mary Eapen; Jennifer Le Rademacher; Joseph H Antin; Richard E Champlin; Jeanette Carreras; Joseph Fay; Jakob R Passweg; Jakub Tolar; Mary M Horowitz; Judith C W Marsh; H Joachim Deeg
Journal:  Blood       Date:  2011-06-15       Impact factor: 22.113

7.  Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience.

Authors:  Sujith Samarasinghe; Colin Steward; Prashant Hiwarkar; Muhammad Ameer Saif; Rachael Hough; David Webb; Alice Norton; Sarah Lawson; Amrana Qureshi; Philip Connor; Peter Carey; Rod Skinner; Ajay Vora; Maria Pelidis; Brenda Gibson; Graham Stewart; Steve Keogh; Nick Goulden; Denise Bonney; Mathew Stubbs; Persis Amrolia; Kanchan Rao; Stefan Meyer; Rob Wynn; Paul Veys
Journal:  Br J Haematol       Date:  2012-02-29       Impact factor: 6.998

8.  Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.

Authors:  Andrea Bacigalupo; Gerard Socié; Rose Marie Hamladji; Mahmoud Aljurf; Alexei Maschan; Slawomira Kyrcz-Krzemien; Alicja Cybicka; Henrik Sengelov; Ali Unal; Dietrich Beelen; Anna Locasciulli; Carlo Dufour; Jakob R Passweg; Rosi Oneto; Alessio Signori; Judith C W Marsh
Journal:  Haematologica       Date:  2015-01-23       Impact factor: 9.941

9.  Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.

Authors:  Mark Lawler; Shaun R McCann; Judith C W Marsh; Per Ljungman; Jill Hows; Elisabeth Vandenberghe; Joan O'Riordan; Anna Locasciulli; Gérard Socié; Alan Kelly; Hubert Schrezenmeier; Pedro Marin; André Tichelli; Jakob R Passweg; Anne Dickenson; Jacqueline Ryan; Andrea Bacigalupo
Journal:  Br J Haematol       Date:  2009-01-09       Impact factor: 6.998

10.  Outcomes of hematopoietic cell transplantation in adult patients with acquired aplastic anemia using intermediate-dose alemtuzumab-based conditioning.

Authors:  Nada Hamad; Ryan Del Bel; Hans A Messner; Dennis Kim; John Kuruvilla; Jeffrey H Lipton; Jieun Uhm; Matthew Seftel; Naheed Alam; Wei Xu; Vikas Gupta
Journal:  Biol Blood Marrow Transplant       Date:  2014-07-10       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.